Paul Lévesque
Chief Executive Officer at THERATECHNOLOGIES INC.
Net worth: 120 848 $ as of 2024-03-30
Profile
Paul Lévesque is currently the President, Chief Executive Officer & Director at Theratechnologies, Inc. He previously worked as the Global President-Rare Disease at Pfizer Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed his undergraduate degree at McGill University and Université Laval.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0.16% | 2024-01-20 | 72,800 ( 0.16% ) | 120 848 $ | 2024-03-30 |
Paul Lévesque active positions
| Companies | Position | Start |
|---|---|---|
| THERATECHNOLOGIES INC. | Chief Executive Officer | 2020-04-05 |
Former positions of Paul Lévesque
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 2020-04-05 |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Chief Tech/Sci/R&D Officer | - |
Training of Paul Lévesque
| Université Laval | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Private companies | 1 |
|---|---|
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
- Stock Market
- Insiders
- Paul Lévesque
